Recent INZY News
- Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference • GlobeNewswire Inc. • 05/08/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 12:33:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 12:32:27 PM
- Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights • GlobeNewswire Inc. • 05/07/2024 12:30:44 PM
- Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/03/2024 12:30:02 PM
- Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency • GlobeNewswire Inc. • 04/08/2024 10:30:35 AM
- Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/05/2024 10:00:00 PM
- Inozyme Pharma to Participate at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/02/2024 12:30:03 PM
- Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024 • GlobeNewswire Inc. • 03/26/2024 12:30:42 PM
- Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights • GlobeNewswire Inc. • 03/12/2024 12:30:16 PM
- Inozyme Pharma to Participate in the TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/26/2024 01:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:48:34 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/13/2024 02:06:26 AM
- Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/06/2024 01:30:48 PM
- Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 12/05/2023 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/16/2023 05:15:21 AM
- Inozyme Pharma to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/09/2023 01:30:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/07/2023 09:07:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 01:34:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 01:31:41 PM
- Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights • GlobeNewswire Inc. • 11/07/2023 01:30:00 PM
- Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/03/2023 08:15:00 PM
- Inozyme Pharma Announces Presentation at the American Society of Nephrology (ASN) Kidney Week 2023 • GlobeNewswire Inc. • 10/26/2023 12:30:00 PM
- Inozyme Pharma Highlights Inclusion of Generalized Arterial Calcification of Infancy (GACI) in Genomics England’s Generation Study of Rare Conditions • GlobeNewswire Inc. • 10/10/2023 12:30:00 PM
- Inozyme Pharma Announces Three Poster Presentations at the American Society for Bone and Mineral Research (ASBMR) 2023 Annual Meeting • GlobeNewswire Inc. • 10/06/2023 12:30:00 PM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM